| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |